GRAIL Inc Secures $325 Million in Private Placement

The latest update is out from GRAIL Inc ( (GRAL) ).

On October 18, 2025, GRAIL, Inc. entered into a Securities Purchase Agreement for a private placement, expected to raise approximately $325 million. The proceeds will support GRAIL’s commercial activities, reimbursement efforts, and general corporate purposes, with the closing expected on October 21, 2025. This financing round includes participation from new and existing institutional investors and is anticipated to fund operations into 2030, excluding a separate $110 million investment from Samsung. The private placement is exempt from registration under the Securities Act, with GRAIL agreeing to file a registration statement for the resale of shares.

The most recent analyst rating on (GRAL) stock is a Buy with a $75.00 price target. To see the full list of analyst forecasts on GRAIL Inc stock, see the GRAL Stock Forecast page.

Spark’s Take on GRAL Stock

According to Spark, TipRanks’ AI Analyst, GRAL is a Neutral.

GRAIL Inc.’s overall stock score reflects strong revenue growth and positive developments from the earnings call, tempered by significant profitability challenges and poor valuation metrics. The technical analysis indicates bearish momentum, further impacting the score.

To see Spark’s full report on GRAL stock, click here.

More about GRAIL Inc

GRAIL, Inc. is a healthcare company focused on early cancer detection using next-generation sequencing, clinical studies, and advanced technologies. The company aims to alleviate the global cancer burden by identifying multiple cancer types at earlier stages. GRAIL is headquartered in Menlo Park, CA, with locations in Washington, D.C., North Carolina, and the United Kingdom.

Average Trading Volume: 929,807

Technical Sentiment Signal: Buy

Current Market Cap: $2.81B

For detailed information about GRAL stock, go to TipRanks’ Stock Analysis page.